AbbVie vs Qualcomm: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Qualcomm was founded in 1985 by Irwin Jacobs, Andrew Viterbi and is led by Cristiano Amon.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Qualcomm
Irwin Jacobs
Irwin Jacobs is an American electrical engineer who co-founded Qualcomm and was its first CEO. He had been a professor at UC San Diego and had co-founded Linkabit.
Andrew Viterbi
Andrew Viterbi brought the deepest technical credentials of Qualcomm's founding team, combining top academic training in communications theory with practical experience in defense and commercial digital systems.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Qualcomm
- Steve Mollenkopf2013–2021
Chief Executive Officer
As CEO, he navigated the company through brutal antitrust litigation with Apple and the FTC, securing the critical 5G licensing agreements that stabilized Qualcomm's revenue model.
Source - Akash Palkhiwala2019–present
Chief Financial Officer and Chief Operating Officer
As CFO, he executed massive share repurchase programs and maintained strong gross margins despite extreme volatility in global smartphone demand.
Source - Cristiano Amon2021–present
President and Chief Executive Officer
Cristiano Amon, a Brazilian electrical engineer, joined Qualcomm in 1995 and led its QCT chip business and president role before becoming CEO on June 30, 2021, succeeding Steve Mollenkopf.
Source
Timeline: AbbVie and Qualcomm side by side
1985Qualcomm
Qualcomm Founded
Irwin Jacobs, Andrew Viterbi, and five colleagues found Qualcomm Incorporated in San Diego, California, initially operating as a telecommunications consulting and research firm from a converted restaurant building.
1988Qualcomm
OmniTRACS Commercial Launch
Qualcomm commercially launches OmniTRACS, a satellite-based two-way messaging and positioning system for long-haul trucking that becomes the company's first profitable product and funds ongoing CDMA research.
1989Qualcomm
First Live CDMA Demonstration
Qualcomm conducts its first outdoor live CDMA demonstration in San Diego, proving the technology works in real-world conditions and attracting serious attention from U.S. Cellular carriers and equipment manufacturers.
1991Qualcomm
Initial Public Offering
Qualcomm goes public on the Nasdaq Stock Market in December 1991, raising approximately $43 million at $16 per share in an IPO that gives the company capital to accelerate CDMA commercialization.
1993Qualcomm
IS-95 CDMA Standard Adopted
The Telecommunications Industry Association formally adopts IS-95, a CDMA standard based substantially on Qualcomm's technology, as an approved digital cellular standard in the United States validating the company's decade-long technological bet.
1995Qualcomm
First Commercial CDMA Network Launched
Sprint PCS launches the first commercial CDMA cellular network in the United States, using Qualcomm-based technology and marking the beginning of large-scale commercial deployment that would define U.S. Wireless infrastructure for the next twenty years.
1999Qualcomm
Strategic Exit from Infrastructure and Handsets
Qualcomm sells its network infrastructure division to Ericsson and its handset manufacturing business to Kyocera, focusing the company entirely on chip design and patent licensing a strategic concentration that defines its business model to the present day.
2007Qualcomm
Snapdragon Platform Introduction
Qualcomm introduces the Snapdragon brand for its mobile system-on-chip processors, establishing a consumer-facing identity for its mobile silicon that would become synonymous with premium Android smartphone performance over the following decade.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2019Qualcomm
Apple Settlement and Licensing Agreement
Following years of contentious litigation, Qualcomm and Apple reach a global settlement in April 2019 covering all pending litigation worldwide, with Apple agreeing to a multi-year chip supply deal and a licensing arrangement reportedly involving back payments…
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2021Qualcomm
Nuvia Acquisition
Qualcomm acquires Nuvia, a CPU startup founded by former Apple Silicon architects, for approximately $1.4 billion, bringing custom CPU design capabilities in-house that power the Oryon cores in Snapdragon 8 Elite and Snapdragon X Elite PC chips.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Qualcomm
Snapdragon X Elite PC Platform Launch
Qualcomm launches the Snapdragon X Elite and Snapdragon X Plus platforms for Windows PCs, powering Microsoft's Copilot+ PC initiative and marking the company's most significant push into personal computing since the failed Snapdragon 835 PC effort in 2017.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024Qualcomm
Snapdragon 8 Elite Launch
Qualcomm launches the Snapdragon 8 Elite, its first phone chip with custom Oryon CPU cores, built on TSMC's 3nm process.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Qualcomm
Alphawave Semi Acquisition Completed
Qualcomm completes its roughly $2.4B purchase of Alphawave Semi to accelerate data center connectivity products.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Qualcomm
Q2 FY2026 Results and $20B Buyback Authorization
Qualcomm reports Q2 FY2026 revenue of $10.599B, record quarterly QCT automotive revenue, 20% year-over-year growth in combined QCT automotive and IoT revenue, and a new $20B repurchase authorization.
2026Qualcomm
Q3 FY2026 Results and $40B Non-Handset Target
Qualcomm reports Q3 FY2026 revenue of $9.9B (down 4%), automotive revenue up 61% to $1.6B, and raises its FY2029 non-handset revenue target to $40B.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Qualcomm
- Modular2026$3.9B
- Alphawave Semi2025$2.4B
- Veoneer Active Safety (ADAS Division)2022$4.5B
- Nuvia2021$1.4B
- RF360 Holdings (joint venture buyout)2019Undisclosed
- Atheros Communications2011$3.1B
Questions about AbbVie vs Qualcomm
Who is the CEO of AbbVie Inc. and Qualcomm Inc.?
AbbVie Inc. is led by Robert A. Michael and Qualcomm Inc. is led by Cristiano Amon. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Qualcomm Inc.?
Qualcomm Inc. was founded in 1985 — 28 years before AbbVie Inc., which was founded in 2013. Qualcomm Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Qualcomm Inc.?
AbbVie Inc. employs approximately 57,000 people, while Qualcomm Inc. employs approximately 52,000. AbbVie Inc. has the larger workforce at 57,000 employees, compared to Qualcomm Inc.'s 52,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Qualcomm Inc. headquartered?
Both AbbVie Inc. and Qualcomm Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Qualcomm Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Qualcomm Inc. was founded by Irwin Jacobs, Andrew Viterbi.
Which company has a longer operating history — AbbVie Inc. or Qualcomm Inc.?
Qualcomm Inc. has been operating for approximately 41 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Qualcomm overview